Joo, M.W.; Park, S.-J.; Kim, W.; Kim, Y.; Cho, J.H.; Bernthal, N.M.; Lee, M.; Lee, J.; Lee, Y.-S.
Which Clinical Factors Are Associated with the Post-Denosumab Size Reduction of Giant Cell Tumors? The Korean Society of Spinal Tumor (KSST) Multicenter Study 2023-02. Cancers 2025, 17, 2121.
https://doi.org/10.3390/cancers17132121
AMA Style
Joo MW, Park S-J, Kim W, Kim Y, Cho JH, Bernthal NM, Lee M, Lee J, Lee Y-S.
Which Clinical Factors Are Associated with the Post-Denosumab Size Reduction of Giant Cell Tumors? The Korean Society of Spinal Tumor (KSST) Multicenter Study 2023-02. Cancers. 2025; 17(13):2121.
https://doi.org/10.3390/cancers17132121
Chicago/Turabian Style
Joo, Min Wook, Se-Jun Park, Wanlim Kim, Yongsung Kim, Jae Hwan Cho, Nicholas Matthew Bernthal, Minpyo Lee, Jewoo Lee, and Yong-Suk Lee.
2025. "Which Clinical Factors Are Associated with the Post-Denosumab Size Reduction of Giant Cell Tumors? The Korean Society of Spinal Tumor (KSST) Multicenter Study 2023-02" Cancers 17, no. 13: 2121.
https://doi.org/10.3390/cancers17132121
APA Style
Joo, M. W., Park, S.-J., Kim, W., Kim, Y., Cho, J. H., Bernthal, N. M., Lee, M., Lee, J., & Lee, Y.-S.
(2025). Which Clinical Factors Are Associated with the Post-Denosumab Size Reduction of Giant Cell Tumors? The Korean Society of Spinal Tumor (KSST) Multicenter Study 2023-02. Cancers, 17(13), 2121.
https://doi.org/10.3390/cancers17132121
